Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 757-761

  Doern, Gary V ^a   Brueggemann, Angela B ^b   Blocker, Michael ^b   Dunne, Michael ^b   Holley Jr , H Preston ^b   Kehl, Karen Sue ^b   Duval, Jen ^b   Kugler, Kari ^b   Putnam, Shannon ^b   Rauch, Allan ^b   Pfaller, Michael A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 2442731883     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514937     Document Type: Article

References (37)

1. Kislak JW, Razavi LMD, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. Am J Med Sci 1965; 250:261-8.
2. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ, the Pneumococcus Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States. 1979-1987. J Infect Dis 1991; 163: 1273-8.
3. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990; 34:2075-80.
4. Thornsberry C, Brown SD, Yee C, Bouchillon SK, Marier JK, Rich T. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S. Suppl Infect Med 1993;93:15-24.
5. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994;38:2419-25.
6. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
7. 6a. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 1998;27:764-70.
8. Waltman WD II, Talkington DF, Lipinski AE, Crain MJ, Dixon MS, Briles DE. Evidence for a clonal origin of relative penicillin resistance among type 9L pneumococci in northwestern Canada. J Infect Dis 1992; 165: 671-5.
9. Munoz R, Musser JM, Crain M, et al. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis 1992; 15:112-8.
10. Munoz R, Coffey TJ, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991; 164:302-6.
11. McDougal LK, Facklam R, Reeves M, et al. Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother 1992;36:2176-84.
12. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae: the role of Streptococcus mitis in the formation of a low affinity PBP 2B in S. pneumoniae. Mol Microbiol 1993; 9:635-43.
13. Laible G, Spratt BG, Hakenbeck R. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1991; 5: 1993-2002.
14. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 3rd ed. NCCLS document M7-A3. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
15. Lefevre JC, Faucon G, Sicard AM, Gasc AM. DNA fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel electrophoresis. J Clin Microbiol 1993;31:2724-8.
16. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 6th information supplement. NCCLS document M100-S6. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1995.
18. McDougal LK, Rasheed JK, Biddle JW, Tenover FC. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob Agents Chemother 1995; 39:2282-8.
19. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168:158-63.
20. Hall LMC, Whiley RA, Duke B, George RC, Efstrautiou A. Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol 1996; 34:853-9.
21. Moissenet D, Valcin M, Marchand V, et al. Molecular epidemiology of Streptococcus pneumoniae with decreased susceptibility to penicillin in a Paris children's hospital. J Clin Microbiol 1997; 35:298-301.
22. Scott JAG, Hall AJ, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 1996; 22:973-81.
23. Castaneda E, Leal AL, Castillo O, et al. Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian children. Microb Drug Res 1997; 3:147.
24. Gratten M, Torzillo P, Morey F, et al. Distribution of capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae isolated from Aborigines in central Australia. J Clin Microbiol 1996; 34:338-41.
25. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171:885-9.
26. Butler JC. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. Microb Drug Res 1997; 3:125.
27. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996; 128:649-53.
28. Siber GR. Pneumococcal disease: prospects for a new generation of vaccines. Science 1994; 265:1385-7.
29. Kayhaty H, Ahman H, Ronnberg RP, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995; 172:1273-8.
30. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996; 174:1271-8.
31. Keyserling HL, Anderson AL, Martin TJ. Immunogenicity of a tetravalent (types 6B, 14, 19F, and 23F) pneumococcal conjugate vaccine in infants [abstract]. In: Proceedings of the annual meeting of the Society for Pediatric Research (Washington, DC). 1993.
32. Yogev R, Gupta S, Emanuel B, Williams K, Adams J. Safety, tolerability and immunogenicity of tetravalent (6B, 14, 19F, and 23F) pneumococcal (Pnc) conjugate vaccine in infants given concurrently with routine immunizations [abstract]. In: Proceedings of the annual meeting of the Society for Pediatric Research (Washington, DC). 1993.
33. Keyserling H, Bosley C, Starr S, et al. Immunogenicity of pneumococcal type 14 conjugate vaccine [abstract]. In: Proceedings of the annual meeting of the Society for Pediatric Research (Seattle). 1994.
34. Swartz MM. Use of antimicrobial agents and drug resistance. N Engl J Med 1997; 337:491-2.
35. American Society for Microbiology. Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother 1995; suppl:1-23.
36. Moberg CL. Rene Dubos: a harbinger of microbial resistance to antibiotics. Microb Drug Res 1996; 2:287-97.
37. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337:441-6.